Reents Scott T
Insider CIK 1937048 · ABBV EVP, CHIEF FINANCIAL OFFICER
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ABBV AbbVie Inc. | F Tax w/h | 2026-02-27 | 2026-03-03 | 21,638 | $232.08 | $5.02M | 38,777 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2026-02-18 | 2026-02-20 | 21,937 | — | $0 | 21,937 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2026-02-18 | 2026-02-20 | 8,910 | — | $0 | 45,549 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2026-02-18 | 2026-02-20 | 25,062 | — | $0 | 36,639 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2026-02-18 | 2026-02-20 | 7,606 | — | $0 | 53,155 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2026-02-18 | 2026-02-20 | 7,260 | — | $0 | 60,415 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2025-03-14 | 2025-03-18 | 17,644 | $212.34 | $3.75M | 11,577 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2025-02-28 | 2025-03-04 | 10,973 | $205.02 | $2.25M | 29,221 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2025-02-13 | 2025-02-18 | 27,343 | — | $0 | 27,343 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2025-02-13 | 2025-02-18 | 8,912 | — | $0 | 32,586 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2025-02-13 | 2025-02-18 | 2,398 | — | $0 | 23,674 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2025-02-13 | 2025-02-18 | 5,845 | — | $0 | 21,276 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2025-02-13 | 2025-02-18 | 7,608 | — | $0 | 40,194 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2024-02-28 | 2024-03-01 | 11,634 | $178.99 | $2.08M | 15,431 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2024-02-23 | 2024-03-01 | 14,140 | $61.36 | $867.6K | 17,380 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2024-02-23 | 2024-03-01 | 14,140 | $61.36 | $867.6K | 41,205 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2024-02-23 | 2024-03-01 | 14,140 | $177.44 | $2.51M | 27,065 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2024-02-15 | 2024-02-20 | 31,520 | — | $0 | 31,520 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2024-02-15 | 2024-02-20 | 8,912 | — | $0 | 27,065 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2024-02-15 | 2024-02-20 | 11,800 | — | $0 | 12,609 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2024-02-15 | 2024-02-20 | 3,146 | — | $0 | 15,755 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2024-02-15 | 2024-02-20 | 2,398 | — | $0 | 18,153 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2023-03-01 | 2023-03-02 | 15,092 | $153.06 | $2.31M | 1,659 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2023-03-01 | 2023-03-02 | 850 | $153.38 | $130.4K | 809 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2023-02-28 | 2023-03-02 | 12,683 | $154.28 | $1.96M | 16,751 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2023-02-16 | 2023-02-21 | 33,760 | — | $0 | 33,760 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2023-02-16 | 2023-02-21 | 3,146 | — | $0 | 27,036 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2023-02-16 | 2023-02-21 | 18,715 | — | $0 | 19,524 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2023-02-16 | 2023-02-21 | 2,398 | — | $0 | 29,434 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2023-02-16 | 2023-02-21 | 4,366 | — | $0 | 23,890 | SEC↗ |